GENETIC SIGNATURES ORDINARY (GSS) Short Interest
GENETIC SIGNATURES ORDINARY (ASX:GSS) had 0.00% of shares reported as short positions as of 11 July 2026, representing 7,000 shares. GENETIC SIGNATURES ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Unlock advanced features: Custom dashboards, portfolio tracking, real-time alerts, and more
Genetic Signatures
Genetic Signatures is a molecular diagnostics company focused on transforming diagnostics through streamlined sample processing and highly multiplexed real-time PCR screening assays. Their EasyScreen™ Detection Kits aim to simplify and improve the identification of infectious diseases. The company is based in Australia and has a global presence.